相关实验视频

Updated: Jul 6, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

在青少年治疗耐药抑郁症中探索胺反应的预测因素

Alice Lineham¹, Victor J Avila-Quintero¹, Michael H Bloch^1,2

¹Child Study Center, Yale School of Medicine, New Haven, Connecticut, USA.

Journal of child and adolescent psychopharmacology

|January 3, 2024

概括

有较少先前药物试验和较短抑郁期的青少年可能更好地响应胺治疗抑郁症. 需要进一步的研究来确认这些预测因素的临床指导.

科学领域:

神经科学是一个神经科学.
精神病学是一个精神病学.
药理学药理学是指药理学的学科.

背景情况:

胺作为一种快速起作用的抗抑郁药物表现有前途,但它的有效性各不相同.
基他胺反应的预测因素已在成年人中进行研究,但未在患有抑郁症的青少年中进行研究.
青少年治疗耐药性抑郁症仍然是一个重大的临床挑战.

研究的目的:

确定青少年对胺胺抗抑郁药反应的人口和临床预测因素.
分析基他胺在青少年治疗耐药抑郁症的随机试验中的二次数据.
为了探索与胺注后抑郁症症状改善相关的因素.

主要方法:

一个随机的,单剂量,米达佐拉姆受控交叉试验的二次数据分析.
研究了19个探索性人口和临床变量.
评估了使用蒙哥马利-阿斯伯格抑郁评分表 (MADRS) 在输液后1天和7天的抑郁症状改善.

主要成果:

较少的先前抗抑郁药物和增强药物试验预测了更好的胺反应.
当前抑郁情节持续时间较短与更大的症状改善有关.
使用选择性血清素再吸收抑制剂 (SSRI) 而不是血清素-上腺素再吸收抑制剂 (SNRIs) 的治疗预测了更好的反应.
在米达佐拉姆对照组中,较不严重的抑郁症状 (CDRS) 和并发性ADHD预测了反应的增加.

结论:

初步发现表明,抑郁症青少年对胺胺反应的潜在预测因素.
较少的药物试验和较短的发作持续时间可能表明更好的治疗结果.
需要对更大的样本大小进行进一步的研究,以确定青少年抑郁症中胺使用的临床指导.

关键词:

青少年青少年青少年青少年临床试验临床试验临床试验临床试验临床试验胺基氨酸是什么胺基氨酸大型抑郁症主要是抑郁症.预测者预测者预测者

更多相关视频

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...